Certican 0.25mg Tablets (60s)

Product Overview

Certican 0.25mg Tablets are a medication used to prevent rejection in people who have received a kidney or liver transplant. These tablets contain the active ingredient Everolimus, which belongs to a class of drugs known as immunosuppressants. By suppressing the immune system, Certican helps to prevent the body from rejecting the transplanted organ.

Key Benefits

Prevents organ rejection after kidney or liver transplant

- Helps to reduce the risk of infection

- May improve the long-term success of the transplant

- Offers a convenient once-daily dosing schedule

- Available in easy-to-swallow tablet form

How It Works

Everolimus works by inhibiting a protein called mTOR (mammalian target of rapamycin), which is involved in the growth and division of cells in the immune system. By blocking this protein, Certican helps to prevent the immune system from attacking and rejecting the transplanted organ.

Storage Instructions

Store Certican tablets in their original packaging at room temperature, away from moisture and heat. Keep the medication out of reach of children and pets.

Directions for Use

1. Take Certican tablets exactly as prescribed by your healthcare provider.

2. Swallow the tablets whole with a full glass of water.

3. It is recommended to take Certican at the same time each day.

4. Do not crush, chew, or break the tablets.

5. If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.

Precautions

Inform your healthcare provider about all medications you are currently taking, including over-the-counter drugs and supplements.

- Do not receive any live vaccines while taking Certican.

- Avoid exposure to sunlight and UV light, as Everolimus may increase the risk of skin cancer.

- Contact your doctor immediately if you experience signs of infection, such as fever, chills, or sore throat.

Manufacturer Information

Certican 0.25mg Tablets are manufactured by Novartis, a leading pharmaceutical company known for its innovative and high-quality products in the field of transplant medicine. Novartis is committed to improving patient outcomes and quality of life through their research and development efforts.